Press Releases Burning Rock Biotech Limited

Equities

BNR

US12233L1070

Delayed Nasdaq Other stock markets 10:44:53 2024-05-08 am EDT			5-day change	1st Jan Change
0.8011 ^USD	+1.41%		+7.13%	-13.86%

Apr. 02	Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Revenue $75.7M	MT
Apr. 02	Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Loss $-0.90	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Burning Rock Publishes 2023 Annual Report on Form 20-F	Apr. 29	GL
Burning Rock Biotech : 2023 Annual Report	Apr. 29	PU
Burning Rock Announces ADS Ratio Change	Apr. 26	GL
Burning Rock Announces ADS Ratio Change	Apr. 26	AQ
Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results	Mar. 28	GL
Burning Rock Announces Receipt of Notification from NASDAQ	Jan. 04	GL
Burning Rock Announces Results of 2023 Annual General Meeting	Dec. 19	GL
Burning Rock Reports Third Quarter 2023 Financial Results	Nov. 30	GL
Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023	Nov. 22	GL
Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023	Nov. 20	GL
Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics	23-10-30	GL
Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection Test	23-10-15	GL
Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer Cell	23-09-07	GL
Burning Rock Reports Second Quarter 2023 Financial Results	23-08-31	GL
Burning Rock Biotech : Q2 2023 Presentation Slides	23-08-31	PU
Burning Rock Provides Second Quarter 2023 Business Updates and Schedules Earnings Release on August 31, 2023	23-08-04	GL
Burning Rock Announces Resignation and Appointment of Directors	23-06-28	GL
Burning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment, with results published in the New England Journal of Medicine	23-06-08	GL
Burning Rock Reports First Quarter 2023 Financial Results	23-05-30	GL
Burning Rock Biotech : Q1 2023 Presentation Slides	23-05-29	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Burning Rock Biotech Limited

Equities

BNR

US12233L1070

Press Releases

Filters